Sri Lanka Turns To Bangladesh For Drugs Blacklisted India Firms Sold
This article was originally published in PharmAsia News
Sri Lanka's health ministry is taking steps to begin importing drugs in 122 categories from Bangladesh to prevent a shortage brought about by a decision to ban drugs from four Indian drug makers it did not identify.
You may also be interested in...
The US FDA issued only one device-related close-out letter in October.
Seven pharmacies have filed a lawsuit against the FDA claiming the agency exceeded its statutory authority in its final standard memorandum of understanding on interstate compounding and that the MOU will have an adverse impact on compounding pharmacies and patients.
Several experts spoke with Scrip about their take on how the biopharmaceutical industry's efforts to respond to COVID-19 might help industry's image problem.